Legend Biotech (LEGN) Tax Provisions (2019 - 2025)
Legend Biotech (LEGN) posted Tax Provisions of -$11.2 million for Q4 2025, down 1718.18% quarter-over-quarter from -$616000.0 in Q3 2025, and up 21.13% year-on-year from -$9.2 million in Q4 2024.
Legend Biotech (LEGN) Tax Provisions (2019 - 2025) Analysis & Trends
Legend Biotech (LEGN) has reported Tax Provisions for 7 consecutive years, with -$11.2 million the latest figure, recorded in Q4 2025.
- Tax Provisions for Q4 2025 came in at -$11.2 million, up 21.13% year-over-year; the trailing twelve-month figure through Dec 2025 was -$14.2 million (up 24.82% YoY), and the FY2025 annual result was -$14.2 million, up 24.87% from the prior year.
- Tax Provisions was -$11.2 million for Q4 2025 at Legend Biotech, down from -$616000.0 in the prior quarter.
- Over five years, Tax Provisions peaked at $3.6 million in Q4 2021 and troughed at -$14.2 million in Q4 2024.
- Average Tax Provisions over 5 years is -$1.6 million, with a median of -$157000.0 recorded in 2022.
- Year-over-year, Tax Provisions jumped 5120.83% in 2021 and sank 712236.41% in 2024.
- Over 5 years, Tax Provisions stood at $3.6 million in 2021, then slumped by 104.23% to -$153000.0 in 2022, then surged by 101.3% to $1994.0 in 2023, then tumbled by 712236.41% to -$14.2 million in 2024, then gained by 21.13% to -$11.2 million in 2025.
- Per Business Quant data, the three most recent Tax Provisions figures were -$11.2 million in Q4 2025, -$616000.0 in Q3 2025, and -$582000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Genmab A | 276,399.99 Bn | 276,398.47 Bn | 831.00 Mn | - |
| 2 | Akari Therapeutics | 1,217.26 Bn | 1,217.26 Bn | - | -859,000.00 |
| 3 | BeOne Medicines | 419.38 Bn | 414.59 Bn | 1.35 Bn | 31.86 Mn |
| 4 | Vertex Pharmaceuticals | 126.54 Bn | 119.30 Bn | 2.59 Bn | 221.50 Mn |
| 5 | Pharming | 110.17 Bn | 110.12 Bn | 65.80 Mn | -459,000.00 |
| 6 | Regeneron Pharmaceuticals | 64.97 Bn | 56.22 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Argenx Se | 56.44 Bn | 56.44 Bn | 1.18 Bn | 60.00 Mn |
| 8 | Alnylam Pharmaceuticals | 40.09 Bn | 37.08 Bn | 959.66 Mn | 15.66 Mn |
| 9 | Revolution Medicines | 37.15 Bn | 37.15 Bn | - | - |
| 10 | Legend Biotech | 11.04 Bn | 10.14 Bn | 242.10 Mn | -11.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -11.20 Mn |
| Sep 30, 2025 | -616,000.00 |
| Jun 30, 2025 | -582,000.00 |
| Mar 31, 2025 | -1.79 Mn |
| Dec 31, 2024 | -14.20 Mn |
| Sep 30, 2024 | -4.44 Mn |
| Jun 30, 2024 | -226,000.00 |
| Mar 31, 2024 | -5,000.00 |
| Dec 31, 2023 | 1,994.00 |
| Sep 30, 2023 | 288,000.00 |
| Jun 30, 2023 | -290,000.00 |
| Mar 31, 2023 | -128,000.00 |
| Dec 31, 2022 | -153,000.00 |
| Sep 30, 2022 | -152,000.00 |
| Jun 30, 2022 | -157,000.00 |
| Mar 31, 2022 | -163,000.00 |
| Dec 31, 2021 | 3.62 Mn |
| Jun 30, 2021 | -5,082.00 |
| Mar 31, 2021 | 4,082.00 |
| Dec 31, 2020 | -72,000.00 |